EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip Breitfeld, MD
EMD Serono, Inc., Rockland MA, a subsidiary of Merck KGaA, Darmstadt, Germany
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Brussels, Belgium
- Uz Gent
Ghent, Belgium
- Research Site
Wilrijk, Belgium
- Cliniques Universitaires Mont-Godinne
Yvoir, Belgium
- Research Site
Brno, Czechia
- Research Site
Kladno, Czechia
- Research Site
Pardubice, Czechia
- Ustav Radiacni Onkologie Fakultni Nemacnice Na Bulovce
Prague, Czechia
- Research Site
Montpellier, France
- Research Site
Villejuif, France
- Research Site
Győr, Hungary
- Research Site
Kecskemét, Hungary
- Research Site
Miskolc, Hungary
- Research Site
Nyiregyahaza, Hungary
- Szegedi Tudomayegyetem Altalanos Orvostudomanyi Kar Onkoterapias Klinika
Szeged, Hungary
- Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet
Szolnok, Hungary
- Zala Megyei Kohaz Kulsokorhaz Onkologia Osztaly
Zalaegerszeg, Hungary
- Spzoz Centrum Onkologi Liemi Lubelskiej, Ii Odzial Radioterapiii Z Pododdzialem Chemioterpii
Lublin, Poland
- Zaklad Opleki Zdrowotnej Mswia Z Warminsko-Mazurskim Centrum Onkologil, Oddziat Chemioterapli
Olsztyn, Poland
- Centrum Onkologi - Instytut Im. Marii Sklodowskiej-Curie, Klinika Nowotworow Glowy I Szyi (nci)
Warsaw, Poland
- Onkologicky Ustav Sv. Alzbety
Bratislava, Slovakia
- Nemocnice S Poliklinikou Zilina
Žilina, Slovakia
- Velindre Cancer Centre
Cardiff, United Kingdom
- Research Site
Conventry, United Kingdom
- Mhcw
Coventry, United Kingdom
- St. James' University Hospital
Leeds, United Kingdom
- Research Site
London, United Kingdom
- the Christie Nhs Ft
Manchester, United Kingdom
- Research Site
Newcastle upon Tyne, United Kingdom
- Weston Park Hospital
Sheffield, United Kingdom
- Southampton University Hospitals Nhs Trust
Southampton, United Kingdom
- University of Colorado Cancer Center
Aurora, Colorado, United States
- University of Kentucky, Markey Cancer Center
Lexington, Kentucky, United States
- Mgh Massachusetts General Hospital
Boston, Massachusetts, United States
- Montefiore Medical Center Oncology
The Bronx, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2009
- Primary completion
- 31 Jan 2012
- Completion
- —
- Last update posted
- 30 Jan 2017
- Registered enrollment
- 107
- Registry id
- NCT01040832
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.